Epidemiology, clinical presentation, and diagnosis of cervical dystonia

Neurologic Clinics

Volumn 26, Issue SUPPL.1, 2008, Pages 23-42

  Stacy, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE PLUS PERPHENAZINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; CLEBOPRIDE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; METOCLOPRAMIDE;

ARTICLE; CERVICAL DYSTONIA; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSTONIA; ESSENTIAL TREMOR; HUMAN; HYPERKINESIA; PRIORITY JOURNAL; REMISSION; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; TREMOR;

DIAGNOSIS, DIFFERENTIAL; HUMANS; TORTICOLLIS;

EID: 46049113062     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(08)80003-5     Document Type: Article

References (71)

1. Velickovic M., Benabou R., and Brin M. Cervical dystonia pathophysiology and treatment options. Drugs 61 (2001) 1921-1943
2. Nutt J., Muenter M., Aronson A., et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 33 (1988) 188-194
3. The Epidemiological Study of Dystonia in Europe (EESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 247 (2000) 787-792
4. Duffey P., Butler A., Hawthorne M., and Barnes M. The epidemiology of the primary dystonias in the north of England. Adv Neurol 78 (1998) 121-125
5. National Spasmodic Torticollis Association. Spasmodic torticollis.
6. (March 24, 2008). http://www.torticollis.org/home.html Accessed
7. Epidemiologic Study of Dystonia in Europe (EESDE) Collaborative Group. Sex-related influences on the frequency and age of onset of primary dystonia. Neurol 53 (1999) 1871-1883
8. Chan J., Brin M., and Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord 6 (1991) 119-126
9. Jankovic J., Leder S., Warner D., and Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 41 (1991) 1088-1091
10. Rondot P., Marchand M., and Dellatolas G. Spasmodic torticollis: review of 220 patients. Can J Neurol Sci 18 (1991) 143-151
11. Van Zandijcke M. Cervical dystonia (spasmodic torticollis). Some aspects of the natural history. Acta Neurol Belg 95 (1995) 210-215
12. Stacy M. Idiopathic cervical dystonia: an overview. Neurology 555 SSuppl 5 (2000) S2-S8
13. Dauer W., Burke R., Greene P., and Fahn S. Current concepts on the clinical features, etiology and management of idiopathic cervical dystonia. Brain 121 (1998) 547-560
14. Waddy H., Fletcher N., Harding A., and Marsden C. A genetic study of idiopathic focal dystonias. Ann Neurol 29 (1991) 320-324
15. Jankovic J., Tsui J., and Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Rel Disord 13 (2007) 411-446
16. Nutt J., Muenter M., Melton III L., et al. Epidemiology of dystonia in Rochester, Minnesota. Adv Neurol 50 (1988) 361-365
17. Logroscino G., Livrea P., Anaclerio D., et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry 74 (2003) 348-350
18. Fahn S. Dystonia. In: Jankovic J., and Hallett M. (Eds). Therapy with Botulinum Toxin. (1994), Marcel Dekker, New York, NY 173-189
19. Dalvi A., Lyons K., and Pahwa R. In: Stacy M. (Ed). Handbook of Dystonia (2004), Informa Healthcare, London, UK 245-266
20. Kutvonen O., Dastidar P., and Nurmikko T. Pain in spasmodic torticollis. Pain 69 (1997) 279-286
21. Jahanshahi M., Marion M., and Marsden C. Natural history of adult-onset idiopathic torticollis. Arch Neurol 47 (1990) 548-552
22. Friedman A., and Fahn S. Spontaneous remissions in spasmodic torticollis. Neurology 36 (1986) 398-400
23. Dashtipour K., and Lew M. Cervical dystonia. In: Stacy M. (Ed). Handbook of Dystonia (2004), Informa Healthcare, London, UK 137-154
24. Jahanshahi M. Factors that ameliorate or aggravate spasmodic torticollis. J Neurol Neurosurg Psychiatry 68 (2000) 227-229
25. Wissel J., Muller J., Ebersbach G., and Poewe W. Trick maneuvers in cervical dystonia: investigation of movement- and touch-related changes in polymyographic activity. Mov Disord 14 (1999) 994-999
26. Greene P., and Bressman S. Exteroceptive and interoceptive stimuli in dystonia. Mov Disord 13 (1998) 549-551
27. Stephan K., Fink G., Passingham R., et al. Functional anatomy of the mental representation of upper extremity movements in healthy subjects. J Neurophysiol 73 (1995) 373-386
28. Doheny D., Brin M., Morrison C., et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 59 (2002) 1187-1196
29. Rinnerthaler M., Mueller J., Weichbold V., et al. Social stigmatization in patients with cranial and cervical dystonia. Mov Disord 21 (2006) 1636-1640
30. Currá A., Bagnato S., and Berardelli A. Recent findings in cranial and cervical dystonia: how they help us to understand the pathophysiology of dystonia. Suppl Clin Neurophysiol 58 (2006) 257-265
31. Camfield L., Ben-Shlomo Y., Warner T., and For the Epidemiological Study of Dystonia in Europe Collective Group. Impact of cervical dystonia on quality of life. Mov Disord 17 (2002) 838-841
32. Skogseid I., Roislien J., Claussen B., and Kerty E. Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia. Mov Disord 20 (2005) 1604-1609
33. MolhoES, Higgins DS, Celmins DF, et al. Effect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment status. Poster presented at: 10th In nternational Congreess of Parkinson's Disease and Movement Disorders; October 30, 2006; Kyoto, Japan.
34. Comella C., Stebbins G., and Miller S. Specific dystonic factors contributing to work limitation and disability in cervical dystonia. Neurology 46 SSuppl 2 (1996) A259
35. Erbguth F. Pain in cervical dystonia. In: Jost W. (Ed). Botulinum Toxin in Painful Diseases. Pain Headache 14 (2003), Karger, Basel, Switzerland 54-70
36. Lowenstein D., and Aminoff M. The clinical course of spasmodic torticollis. Neurology 38 (1988) 530-532
37. Sheehy M., and Marsden C. Trauma and pain in spasmodic torticollis. Lancet 1 (1980) 77-78
38. Molho E, Lipton RB, Bigal ME, et al. Prevalence of headache attributed to craniocervical dystonia: an epidemiologic study. Poster presented at: 10th International Congress of Parkinson's Disease and Movement Disorders; October 30, 2006; Kyoto, Japan.
39. Dieckmann G., and Veras G. Bipolar spinal cord stimulation for spasmodic torticollis. Appl Neurophysiol 48 (1985) 339-346
40. Korein J., Brudny J., Grynbaum B., et al. Sensory feedback therapy of spasmodic torticollis and dystonia: results in treatment of 55 patients. Adv Neurol 14 (1976) 375-402
41. Jahanshahi M., and Marsden C. Treatments for torticollis [letter]. J Neurol Neurosurg Psychiatry 52 (1989) 1212
42. Jahanshahi M., Sartory G., and Marsden C. EMG biofeedback treatment of torticollis: a controlled outcome study. Biofeedback Self Regul 16 (1991) 413-448
43. Gelb J., Lowenstein H., and Aminoff M. Controlled trial of Botulinum oxin injections in the treatment of spasmodic torticollis. Neurology 39 (1989) 80-84
44. Blackie J., and Lees A. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 53 (1990) 640-663
45. Lorentz I., Subramaniam S., and Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum toxin: a double-blind study on twenty-three patients. Mov Disord 6 (1991) 145-150
46. Consky E., and Lang A. Clinical assessments of patients with cervical dystonia. In: Jankovic J., and Hallett M. (Eds). Therapy with Botulinum Toxin (1994), Marcel Dekker, New York, NY 211-238
47. Jahanshahi M. Psychosocial factors and depression in torticollis. J Psychosomatic Res 35 (1991) 493-507
48. Jahanshahi M., and Marsden C. Depression in torticollis: a controlled study. Psychol Med 18 (1988) 925-933
49. Jahanshahi M., and Marsden C. A longitudinal follow-up study of depression, disability, and body concept in torticollis. Behav Neurol 3 (1990) 233-246
50. Spencer J., Goetsch V., Brugnoli R., and Herman S. Behavior therapy for spasmodic torticollis: a case study suggesting a causal role for anxiety. J Behav Ther Exp Psychiatry 22 (1991) 305-311
51. Gundel H., Wolf A., Xidara V., et al. High psychiatric comorbidity in spasmodic torticollis: a controlled study. J Nerv Ment Dis 191 (2003) 465-473
52. Moraru E., Schnider P., Wimmer A., et al. Relation between depression and anxiety in dystonic patients: implications for clinical management. Depress Anxiety 16 (2002) 100-113
53. Burke R., Fahn S., Jankovic J., et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32 (1982) 135-146
54. Micheli F., Pardal M., Gatto M., et al. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 37 (1987) 881-884
55. Ganzini L., Casey D., Hoffman W., and McCall A. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 153 (1993) 1469-1475
56. Fahn S., Marsden C., and Calne D. Classification and investigation of dystonia. In: Marsden C., and Fahn S. (Eds). Movement Disorders 2 (1987), Butterworths, London, UK 332-358
57. Ruegg S., Buhlmann M., Renaud S., et al. Cervical dystonia as first manifestation of multiple sclerosis. J Neurol 251 (2004) 1408-1410
58. Hagenah J., Zuhlke C., Hellenbroich Y., et al. Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov Disord 19 (2004) 217-220
59. Uziel Y., Rathaus V., Pomeranz A., et al. Torticollis as the sole initial presenting sign of systemic onset juvenile rheumatoid arthritis. J Rheumatol 25 (1998) 166-168
60. Suchowersky O., and Calne D. Non-dystonic causes of torticollis. Adv Neurol 50 (1988) 501-508
61. Kiwak K., Deray M., and Shields W. Torticollis in three children with syringomyelia and spinalcord tumor. Neurology 33 (1983) 946-948
62. Cammarota A., Gershanik O., Garcia S., and Lera G. Cervical dystonia due to spinal cord ependymoma: involvement of cervical cord segments in the pathogenesis of dystonia. Mov Disord 10 (1995) 500-503
63. Meige H., and Feindel E. Tics and their treatment (1907), Appleton, London, UK
64. Jankovic J., and Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord 6 (1991) 248-252
65. Obeso J., Rothwell J., Lang A., and Marsden C. Myoclonic dystonia. Neurology 33 (1983) 825-830
66. Munchau A., Schrag A., Chuang C., et al. Arm tremor in cervical dystonia differs from essential tremor and can be classified by onset age and spread of symptoms. Brain 124 (2001) 1765-1766
67. Pal P., Samii A., Schulzer M., et al. Head tremor in cervical dystonia. Can J Neurol Sci 27 (2000) 137-142
68. Schrag A., and Lang A. Psychogenic dystonia. In: Stacy M. (Ed). Handbook of Dystonia (2004), Informa Healthcare, London, UK 277-288
69. Fahn S., and Williams D. Psychogenic dystonia. Adv Neurol 50 (1988) 431-455
70. Caso Martinez J., and Arranz Arana L. Recurrent torticollis due to cervical osteochondroma. Case report and review of the literature [in Spanish]. An Esp Pediatr 49 (1998) 177-178
71. Langlois M., Richer F., and Chouinard S. New perspectives on dystonia. Can J Neurol Sci 330 Suppl 1 (2003) S34-S44